GlassScriptPhysician profile
Susan Breeden
NPI 1821412925
$4,773.59
in general payments reported to CMS, 2019-2025
33 companies · $32.31 in 2025
The $32.31 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $899 · 2022: $1,207 · 2023: $1,581 · 2024: $1,054 · 2025: $32.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $802.04 | 2021-2025 | |
| Novo Nordisk INC | $740.05 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $385.62 | 2021-2024 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $349.93 | 2021-2024 | Tezspire, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $309.48 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $209.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.05 | 2021-2024 | Jardiance, Synjardy, Ofev |
| Pfizer INC. | $184.22 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $160.56 | 2021-2024 | Trintellix |
| Lilly USA, LLC | $148.17 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $133.85 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $130.21 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.38 | 2022-2024 | Xifaxan |
| Esperion Therapeutics, INC. | $116.62 | 2021-2022 | |
| Bausch Health US, LLC | $106.54 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $100.37 | 2022 | |
| Boston Scientific Corporation | $92.53 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Lundbeck LLC | $77.22 | 2023-2024 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $60.01 | 2021 | |
| Dexcom, INC. | $43.30 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $36.36 | 2023-2024 | Gvoke Hypopen |
| Corium, LLC | $31.93 | 2023 | Adlarity |
| Merck Sharp & Dohme LLC | $30.78 | 2021-2023 | Belsomra |
| Sanofi-Aventis U.S. LLC | $28.52 | 2023 | |
| Astellas Pharma US INC | $25.72 | 2023 | Veozah |
| Inogen, INC. | $22.64 | 2022 | |
| Medtronic, INC. | $22.48 | 2023 | Intellis Adaptivestim |
| Axsome Therapeutics, INC. | $21.96 | 2024 | Auvelity |
| Nevro Corp. | $20.80 | 2023 | Senza |
| Exact Sciences Corporation | $16.42 | 2023 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $15.94 | 2024 | Givlaari |
| Neurocrine Biosciences, INC. | $12.20 | 2021 | |
| Eisai INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Breeden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.